Skip to main content
Have a personal or library account? Click to login
The influence of the distal resection margin length on local recurrence and long- term survival in patients with rectal cancer after chemoradiotherapy and sphincter- preserving rectal resection Cover

The influence of the distal resection margin length on local recurrence and long- term survival in patients with rectal cancer after chemoradiotherapy and sphincter- preserving rectal resection

Open Access
|May 2016

Figures & Tables

Table 1

Clinicopathological features of patients according to distal resection margin (DRM)

Group I (n = 27)Group II (n = 31)Group III (n = 51)All (n = 109)p
Male gender21 (77.8)21 (67.7)33 (64.7)75 (68.8)0.490
Age (years)60 (44–83)64 (37–76)66 (34–82)63 (34–83)0.453
Length of hospitalisation (days)10 (7–52)9 (5–31)9 (3–36)9 (3–52)0.189
Median distance from anal verge to tumor (cm)56880.002
DRM (mm)a5 (1–8)15 (9–20)40 (25–80)20 (1–80)< 0.001
CRM (mm)b10 (1–25)10 (4–30)10 (2–40)10 (1–40)0.284
Ileostomy / Transversostomy22 (81.5)21 (67.7)35 (68.6)78 (71.6)0.509
Surgical complications2 (7.4)5 (16.1)1 (2)8 (7.3)0.058
T0.103
10 (0)0 (0)1 (2)1 (0.9)
21 (3.7)4 (12.9)1 (2)6 (5.5)
326 (96.3)26 (83.9)42 (82.4)94 (86.2)
40 (0)1 (3.2)5 (9.8)6 (5.5)
Missing data0 (0)0 (0)2 (3.9)2 (1.8)
N0.047
014 (51.9)12 (38.7)9 (17.6)35 (32.1)
18 (29.6)15 (48.4)24 (47.1)47 (43.1)
24 (14.8)4 (12.9)15 (29.4)22 (20.2)
Missing data1 (3.7)0 (0)3 (5.9)4 (3.7)
yTc0.039
03 (11.1)4 (12.9)3 (5.9)10 (9.2)
15 (18.5)7 (22.6)2 (3.9)14 (12.8)
27 (25.9)10 (32.3)13 (25.5)30 (27.5)
312 (44.4)9 (29)33 (64.7)54 (49.5)
40 (0)1 (3.2)0 (0)1 (0.9)
yNc0.004
022 (81.5)27 (87.1)26 (51)75 (68.8)
13 (11.1)3 (9.7)17 (33.3)23 (21.1)
22 (7.4)1 (3.2)8 (15.7)11 (10.1)
Regression level0.003
10 (0)4 (20)14 (35.9)18 (23.7)
28 (47.1)5 (25)18 (46.2)31 (40.8)
36 (35.3)6 (30)4 (10.3)16 (21.1)
43 (17.6)5 (25)3 (7.7)11 (14.5)
Vascular invasion1 (8.3)4 (21.1)4 (10.3)9 (12.9)0.477
Perineural invasion0 (0)1 (5.6)4 (10)5 (7.2)0.342
Positive lymph nodes5 (18.5)4 (12.9)25 (49)34 (31.2)0.001

Values are shown as median (range) for ordinal and numeric variables and as frequency (percentage) for nominal variable

a DRM = distal resection margin; Group I, DRM < 8mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

b CRM = circumferential resection margin.

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

Univariate analysis of survival rate: (A)local recurrence-free survival, (B)overall survival rate.

Table 2

Risk factors for time to local recurrence or death using univariate Cox regression analysis

Local recurrence-free survivalOverall survival
Variable (reference group)Hazard Ratio (95 % CI)P-valueHazard Ratio (95 % CI)P-value
Female gender (male)2.3 (0.3; 16.2)0.4110.6 (0.2; 1.6)0.279
Age (years)1.1 (0.9; 1.2)0.3951 (1; 1.1)0.125
Length of hospitalisation (days)1.0 (0.8; 1.2)0.7621 (1; 1.1)0.812
DRM (mm)a1 (1; 1.1)0.2181 (1; 1)0.838
DRM Group III (Group I + Group II)a3.5 (0.4; 33.8)0.2761.4 (0.6; 3.3)0.402
DRMa0.667
DRM Group II ( Group I)a1.3 (0.4; 4.5)0.714
DRM Group III (Group I)1.6 (0.5; 5.1)0.392
CRM (mm)b1 (0.9; 1.2)0.5241 (0.9; 1)0.343
N 2 - 3 (0 - 1)3.6 (0.5; 25.6)0.1991.7 (0.6; 4.4)0.293
yT 0 - 1 (2 - 4)c3.1 (0.3; 29.4)0.3331.2 (0.4; 3.7)0.699
yTc0.017
1 (0)0.2 (0; 1.8)0.15
2 (0)0.4 (0.1; 1.7)0.215
3 (0)0.7 (0.2; 2.3)0.517
4 (0)19.5 (1.6; 234.6)0.019
yN 0 (1-2) c7 (0.7; 67.2)0.0922.4 (1.1; 5.6)0.040
yNc0.020
1 (0)1.6 (0.6; 4.6)0.382
2 (0)4.1 (1.5; 11.2)0.005
Vascular invasion2.4 (0.3; 23.4)0.4410.9 (0.2; 4)0.892
Perineural invasion6.5 (0.7; 62.8)0.1050.9 (0.1; 6.9)0.920

Values are shown as median (range) for ordinal and numeric variables and as frequency (percentage) for nominal variables

a DRM = distal resection margin; Group I, DRM < 8 mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

a DRM = distal resection margin; Group I, DRM < 8 mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

a DRM = distal resection margin; Group I, DRM < 8 mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

a DRM = distal resection margin; Group I, DRM < 8 mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

b CRM = circumferential resection margin.

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

c yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

Multiple analysis of overall survival rate in the three patient groups.

Table 3

Risk factors for time to death using multiple Cox regression analysis

Variable (reference group)Overall survival
Hazard Ratio (95% CI)P-value
yTa0.014
1 (0)0.2 (0; 2.3)0.212
2 (0)0.3 (0.1; 1.5)0.158
3 (0)0.5 (0.1; 1.9)0.309
4 (0)23.1 (1.8; 302.3)0.017
yNa0.034
1 (0)1.5 (0.4; 5.4)0.489
2 (0)4.2 (1.4; 12.6)0.011
DRMb0.871
DRM Group II ( Group I)1.3 (0.3; 5.1)0.690
DRM Group III (Group I)1.4 (0.4; 4.4)0.609

Values are shown as median (range) for ordinal and numeric variables and as frequency (percentage) for nominal variables

a yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

a yT, yN = stage as assessed by pathologic examination of the surgical specimen (after CRT and resection)

b DRM = distal resection margin; Group I, DRM < 8mm; Group II, 8 ≤ DRM ≤ 20 mm; Group III, DRM > 20 mm

DOI: https://doi.org/10.1515/raon-2016-0030 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 169 - 177
Submitted on: Feb 20, 2016
Accepted on: Apr 10, 2016
Published on: May 24, 2016
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2016 Jan Grosek, Vaneja Velenik, Ibrahim Edhemovic, Mirko Omejc, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.